logo

Indian News

Share SHARE

AxoGen-Products-121817.jpg Shares of AxoGen Inc. (AXGN) are up a whopping 205% year-to-date while the Dow Jones U.S. Select Medical Equipment Index, which tracks the performance of companies in the medical equipment subsector, has returned only 32% during the same time frame.

Pharma-121417.jpg Today's Daily Dose brings you news about FDA approval of a seborrheic keratoses product; lifting of clinical hold on Fitusiran trials; disappointing trial results of a pet therapeutics company; an update on the patent infringement suit related to Oxford Immunotec's T-SPOT TB test, a method for diagnosing TB infection, and Verastem's stock offering.

pharma-121517.jpg Clinical trials are major catalysts for biotech/pharma companies as positive study data can boost the stock price while unfavorable results can send the stocks plummeting.

asianmarketlow-121517.jpg Asian markets ended mostly weak on Friday, with uncertainty about the outlook for the Republican tax reform plan weighing on investor sentiment.

Marinus-Pharma-121517.jpg 2017 has been an exceptional year for Marinus Pharmaceuticals Inc. (MRNS) as the stock is up an impressive 823% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index (IBB), which has returned just 18% during the same time frame.

Dec14-up-141217.jpg Here's what is making news at GHDX, ARGX and RMTI.

Follow RTT